Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Analysis of Bacterial Pathogens Causing Complicating HAP in Patients with Secondary Peritonitis

J. Chudáček, P. Špička, M. Kolar, M. Stašek, Š. Kolcún, D. Klos, K. Hricová, P. Mlynarcik, V. Pudová, O. Klementová, R. Horáček

. 2023 ; 12 (3) : . [pub] 20230306

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23002746

BACKGROUND: Diffuse peritonitis is an acute abdominal condition characterized by high mortality. The main treatment modality is surgery, requiring a subsequent prolonged hospital stay. These patients are, among other things, at risk of developing hospital-acquired pneumonia (HAP), which considerably worsens their treatment outcomes. This study aimed to extend the existing knowledge by providing more detailed microbiological characteristics of complicating HAP in patients with secondary peritonitis, including the identification of isolated bacterial pathogens and their potential sources. METHODS: The 2015-2019 retrospective study comprised all patients with an intraoperatively confirmed diagnosis of secondary diffuse peritonitis who were classified in accordance with the quick Sepsis Related Organ Failure Assessment scoring system. RESULTS: HAP developed in 15% of patients. The 90-day mortality rates were 53% and 24% in patients with and without HAP; respectively. The most frequent pathogens responsible for HAP were Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae complex and Enterococcus faecalis. Multidrug resistance to antibiotics was found in 38% of bacterial pathogens. Clonal spread of these bacterial pathogens among patients was not detected. Rather, the endogenous characteristic of HAP was confirmed. CONCLUSIONS: The initial antibiotic therapy of complicating HAP in patients with secondary peritonitis must be effective mainly against enterobacteria, including strains with the production of ESBL and AmpC beta-lactamases, Pseudomonas aeruginosa and Enterococcus faecalis. The study further highlighted the importance of monitoring the respiratory tract bacterial microflora in patients with secondary peritonitis. The results should be used for initial antibiotic treatment of complicating HAP instances.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23002746
003      
CZ-PrNML
005      
20230421100053.0
007      
ta
008      
230413s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/antibiotics12030527 $2 doi
035    __
$a (PubMed)36978393
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Chudáček, Josef $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 976/3, 77515 Olomouc, Czech Republic $1 https://orcid.org/0000000312864044
245    10
$a Analysis of Bacterial Pathogens Causing Complicating HAP in Patients with Secondary Peritonitis / $c J. Chudáček, P. Špička, M. Kolar, M. Stašek, Š. Kolcún, D. Klos, K. Hricová, P. Mlynarcik, V. Pudová, O. Klementová, R. Horáček
520    9_
$a BACKGROUND: Diffuse peritonitis is an acute abdominal condition characterized by high mortality. The main treatment modality is surgery, requiring a subsequent prolonged hospital stay. These patients are, among other things, at risk of developing hospital-acquired pneumonia (HAP), which considerably worsens their treatment outcomes. This study aimed to extend the existing knowledge by providing more detailed microbiological characteristics of complicating HAP in patients with secondary peritonitis, including the identification of isolated bacterial pathogens and their potential sources. METHODS: The 2015-2019 retrospective study comprised all patients with an intraoperatively confirmed diagnosis of secondary diffuse peritonitis who were classified in accordance with the quick Sepsis Related Organ Failure Assessment scoring system. RESULTS: HAP developed in 15% of patients. The 90-day mortality rates were 53% and 24% in patients with and without HAP; respectively. The most frequent pathogens responsible for HAP were Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae complex and Enterococcus faecalis. Multidrug resistance to antibiotics was found in 38% of bacterial pathogens. Clonal spread of these bacterial pathogens among patients was not detected. Rather, the endogenous characteristic of HAP was confirmed. CONCLUSIONS: The initial antibiotic therapy of complicating HAP in patients with secondary peritonitis must be effective mainly against enterobacteria, including strains with the production of ESBL and AmpC beta-lactamases, Pseudomonas aeruginosa and Enterococcus faecalis. The study further highlighted the importance of monitoring the respiratory tract bacterial microflora in patients with secondary peritonitis. The results should be used for initial antibiotic treatment of complicating HAP instances.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Špička, Petr $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 976/3, 77515 Olomouc, Czech Republic $1 https://orcid.org/0000000331662624 $7 xx0233421
700    1_
$a Kolar, Milan $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 976/3, 77515 Olomouc, Czech Republic $1 https://orcid.org/0000000346218868 $7 jn20010310083
700    1_
$a Stašek, Martin $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 976/3, 77515 Olomouc, Czech Republic
700    1_
$a Kolcún, Štefan $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 976/3, 77515 Olomouc, Czech Republic
700    1_
$a Klos, Dušan $u Department of Surgery I, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 976/3, 77515 Olomouc, Czech Republic $1 https://orcid.org/0000000230974418
700    1_
$a Hricová, Kristýna $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 976/3, 77515 Olomouc, Czech Republic
700    1_
$a Mlynarcik, Patrik $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 976/3, 77515 Olomouc, Czech Republic
700    1_
$a Pudová, Vendula $u Department of Microbiology, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 976/3, 77515 Olomouc, Czech Republic
700    1_
$a Klementová, Olga $u Department of Anesthesiology, Resuscitation and Intensive Care, University Hospital Olomouc, Zdravotníků 248/7, 77900 Olomouc, Czech Republic
700    1_
$a Horáček, Rostislav $u Department of Anesthesiology, Resuscitation and Intensive Care, University Hospital Olomouc, Zdravotníků 248/7, 77900 Olomouc, Czech Republic
773    0_
$w MED00195446 $t Antibiotics (Basel, Switzerland) $x 2079-6382 $g Roč. 12, č. 3 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36978393 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230413 $b ABA008
991    __
$a 20230421100045 $b ABA008
999    __
$a ok $b bmc $g 1922652 $s 1188953
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 12 $c 3 $e 20230306 $i 2079-6382 $m Antibiotics (Basel) $n Antibiotics $x MED00195446
LZP    __
$a Pubmed-20230413

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...